OPSI COVID-19 Innovative Response Tracker

COVID-19 R&D Incentive System

Innovative response

Incentive system to support collaborative R&D projects for the creation of new products, processes or systems, or for the introduction of significant improvements in products, processes or systems, relevant in the context of the combat of COVID-19. In this context, Proofs of Concept are supported, aiming at the development of ideas or prototypes that have resulted from R&D projects or that are in progress, and that are close to the market (pre-commercial development). The projects must be developed by firms and R&D institutions in a collaborative way.

Specific issues addressed and anticipated impact

These incentives aim to support collaborative projects (between companies and R&D entities), which respond to the immediate and medium-term needs of the National Health Service (SNS) in the context of COVID-19.

Organisations/institutions involved

ANI - National Innovation Agency.

Leave a Reply

Your email address will not be published. Required fields are marked *

Level(s) of government:
  • National/Federal government
  • Private Sector
  • Non-Profit/Civil Society

Issues being addressed:

  • Patient care
  • Health and safety of responders
  • Social effects of the crisis